Ta-xi-san suppresses atopic dermatitis involved in multitarget mechanism using experimental and network pharmacology analysis

HIGHLIGHTS

• who: Wenbing Zhi et al. from the Shaanxi Academy of Traditional Chinese Medicine (Shaanxi Traditional Chinese Medicine Hospital), Xi`an, China Pharmacy College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China have published the Article: Ta-Xi-San Suppresses Atopic Dermatitis Involved in Multitarget Mechanism Using Experimental and Network Pharmacology Analysis, in the Journal: Evidence-Based Complementary and Alternative Medicine 8 of 18/05/2022
• what: The authors investigate the regulatory effect of TXS on activation of PTGS2 and HSP90AA1. The authors found that the protein expressions of PTGS2 and HSP90AA1 in ears and skin . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.